{"id":7217,"date":"2014-10-15T10:00:37","date_gmt":"2014-10-15T09:00:37","guid":{"rendered":"http:\/\/www.wjst.de\/blog\/?p=7217"},"modified":"2014-10-24T08:35:16","modified_gmt":"2014-10-24T07:35:16","slug":"how-to-cope-with-the-unexpected-incidental-findings","status":"publish","type":"post","link":"https:\/\/www.wjst.de\/blog\/sciencesurf\/2014\/10\/how-to-cope-with-the-unexpected-incidental-findings\/","title":{"rendered":"How to cope with the unexpected &#8211; incidental findings"},"content":{"rendered":"<p>Jane Kaye from Oxford was speaking on the 15th Oct 2014 in Coimbra during the ChipMe meeting about the question &#8220;How to cope withe unexpected &#8211; incidental findings&#8221;.<\/p>\n<p><a href=\"https:\/\/www.wjst.de\/blog\/wp-content\/uploads\/2014\/10\/20141015_111414_DSCF5038.jpg\" data-rel=\"key-image-0\" data-rl_title=\"\" data-rl_caption=\"\" title=\"\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-7223\" src=\"https:\/\/www.wjst.de\/blog\/wp-content\/uploads\/2014\/10\/20141015_111414_DSCF5038.jpg\" alt=\"20141015_111414_DSCF5038\" width=\"1000\" height=\"667\" srcset=\"https:\/\/www.wjst.de\/blog\/wp-content\/uploads\/2014\/10\/20141015_111414_DSCF5038.jpg 1000w, https:\/\/www.wjst.de\/blog\/wp-content\/uploads\/2014\/10\/20141015_111414_DSCF5038-620x413.jpg 620w, https:\/\/www.wjst.de\/blog\/wp-content\/uploads\/2014\/10\/20141015_111414_DSCF5038-749x500.jpg 749w\" sizes=\"auto, (max-width: 1000px) 100vw, 1000px\" \/><\/a><\/p>\n<p>The talk basically refers to a new <a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25248396\">EJHG paper<\/a> dealing with UK10K issues. The UK10K research project<!--more--><\/p>\n<p> is looking at 10,000 UK genome sequences, accessing the role of rare genetic variants in health\u00a0<span style=\"line-height: 1.5;\">and disease. As a research program it cannot follow clinical diagnostic standards\u00a0even when including long-standing cohorts like ALSPAC.\u00a0Pertinent findings relate to diseases being studied, the recognized benefit of research and established management pathways for validation and communication.<br \/>\n<\/span>What are incidental findings? This is a finding of an individual research participant that has a potential health or reproductive importance. \u00a0It is discovered in the course of conducting research but is beyond the aims of the study. But\u00a0why is this an issue? There are so many more detailed and comprehensive datasets out there, many of them with \u00a0implications for health and disease.<br \/>\n<span style=\"line-height: 1.5;\">And of course this changes the social attitudes to personal information. Is it morally wrong not to return that information?\u00a0<\/span>It may help again to separate different domains &#8211; research norms and expectations but clinical relevant data that require further diagnostic and therapeutic measurements. The participant at least has to explicitly consent for the feedback of that specific class of information. \u00a0Findings should be truly clinically significant &#8211; high\u00a0validity, state of the art knowledge (whatever expert is being involved).<br \/>\nFor the researcher there is no obligation to search for potential significant variations but to set up at least a management system\u00a0how to deal with that information &#8212;\u00a0depicted on a four-level scheme from A. Discovery, B. Initial contact, C. Validation, and D. feedback. All information should be returned by a healthcare professional.<br \/>\nI think this is a very rational approach although there are many open questions. A participant from the plenum asked &#8211; when does a research project end, with the end of the funding period? And what is state of the art in genomic medicine?\u00a0Opinion voiced in a single\u00a0research\u00a0paper, some vague expert opinion, or any computer algorithm?<\/p>\n\n<p>&nbsp;<\/p>\n<div class=\"bottom-note\">\n  <span class=\"mod1\">CC-BY-NC Science Surf , accessed 08.04.2026<\/span>\n <\/div>","protected":false},"excerpt":{"rendered":"<p>Jane Kaye from Oxford was speaking on the 15th Oct 2014 in Coimbra during the ChipMe meeting about the question &#8220;How to cope withe unexpected &#8211; incidental findings&#8221;. The talk basically refers to a new EJHG paper dealing with UK10K issues. The UK10K research project &nbsp; CC-BY-NC Science Surf , accessed 08.04.2026<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2,5],"tags":[1629,2650,1595],"class_list":["post-7217","post","type-post","status-publish","format-standard","hentry","category-genetics-biology","category-philosophy-of-science","tag-clinical-geneticists","tag-complex-disease-genetics","tag-ethics"],"_links":{"self":[{"href":"https:\/\/www.wjst.de\/blog\/wp-json\/wp\/v2\/posts\/7217","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.wjst.de\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.wjst.de\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.wjst.de\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.wjst.de\/blog\/wp-json\/wp\/v2\/comments?post=7217"}],"version-history":[{"count":6,"href":"https:\/\/www.wjst.de\/blog\/wp-json\/wp\/v2\/posts\/7217\/revisions"}],"predecessor-version":[{"id":7248,"href":"https:\/\/www.wjst.de\/blog\/wp-json\/wp\/v2\/posts\/7217\/revisions\/7248"}],"wp:attachment":[{"href":"https:\/\/www.wjst.de\/blog\/wp-json\/wp\/v2\/media?parent=7217"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.wjst.de\/blog\/wp-json\/wp\/v2\/categories?post=7217"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.wjst.de\/blog\/wp-json\/wp\/v2\/tags?post=7217"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}